These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19959225)

  • 1. Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel.
    Alani AW; Bae Y; Rao DA; Kwon GS
    Biomaterials; 2010 Mar; 31(7):1765-72. PubMed ID: 19959225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
    Zhao H; Li Q; Hong Z
    Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
    J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.
    Wu H; Zhu L; Torchilin VP
    Biomaterials; 2013 Jan; 34(4):1213-22. PubMed ID: 23102622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(γ-propargyl L-glutamate): the substituent effect.
    Zhao X; Poon Z; Engler AC; Bonner DK; Hammond PT
    Biomacromolecules; 2012 May; 13(5):1315-22. PubMed ID: 22376183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
    Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
    Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.
    Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X
    J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
    Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
    Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
    Zhang L; He Y; Ma G; Song C; Sun H
    Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.
    Xie Z; Guan H; Chen X; Lu C; Chen L; Hu X; Shi Q; Jing X
    J Control Release; 2007 Feb; 117(2):210-6. PubMed ID: 17188776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.
    Zou J; Zhang F; Zhang S; Pollack SF; Elsabahy M; Fan J; Wooley KL
    Adv Healthc Mater; 2014 Mar; 3(3):441-8. PubMed ID: 23997013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.